10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 230 filers reported holding 10X GENOMICS INC in Q3 2022. The put-call ratio across all filers is 0.78 and the average weighting 1.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $36,800,074 | -15.3% | 892,123 | +14.6% | 0.01% | -8.3% |
Q2 2023 | $43,469,876 | +2.7% | 778,472 | +2.6% | 0.01% | -7.7% |
Q1 2023 | $42,347,232 | +52.6% | 759,047 | -0.3% | 0.01% | +44.4% |
Q4 2022 | $27,754,016 | +33.2% | 761,636 | +4.1% | 0.01% | +28.6% |
Q3 2022 | $20,837,000 | -12.4% | 731,634 | +39.2% | 0.01% | -12.5% |
Q2 2022 | $23,791,000 | -37.7% | 525,764 | +4.7% | 0.01% | -27.3% |
Q1 2022 | $38,208,000 | -47.9% | 502,270 | +2.0% | 0.01% | -50.0% |
Q4 2021 | $73,327,000 | +6.0% | 492,256 | +3.6% | 0.02% | -4.3% |
Q3 2021 | $69,175,000 | -35.9% | 475,164 | -13.8% | 0.02% | -36.1% |
Q2 2021 | $107,914,000 | +12.8% | 551,089 | +4.3% | 0.04% | +2.9% |
Q1 2021 | $95,672,000 | +47.6% | 528,574 | +15.5% | 0.04% | +34.6% |
Q4 2020 | $64,809,000 | +21.2% | 457,685 | +6.7% | 0.03% | +4.0% |
Q3 2020 | $53,459,000 | +944.7% | 428,763 | +648.4% | 0.02% | +733.3% |
Q2 2020 | $5,117,000 | +73.6% | 57,293 | +21.1% | 0.00% | +50.0% |
Q1 2020 | $2,948,000 | -16.4% | 47,301 | +2.3% | 0.00% | 0.0% |
Q4 2019 | $3,527,000 | – | 46,251 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Venrock Management VI, LLC | 8,185,565 | $952,538,000 | 99.56% |
Foresite Capital Management I, LLC | 2,750,000 | $342,870,000 | 96.54% |
Foresite Capital Management II, LLC | 3,503,528 | $436,820,000 | 95.05% |
12 West Capital Management LP | 1,922,000 | $239,635,000 | 11.66% |
FINANCIAL CONSULATE, INC | 163,366 | $20,368,000 | 9.67% |
JS Capital Management LLC | 606,400 | $75,606,000 | 3.91% |
Asymmetry Capital Management, L.P. | 43,512 | $5,425,000 | 3.49% |
Pinz Capital Management, LP | 55,400 | $6,907,000 | 2.52% |
HAMILTON LANE ADVISORS LLC | 37,087 | $4,624,000 | 2.24% |
RTW INVESTMENTS, LP | 660,933 | $82,405,000 | 1.98% |